pharma · Multiple Myeloma · Ovarian Cancer · CASIF
CASI Pharmaceuticals
CASI Pharmaceuticals is a pharma organization headquartered in San Francisco, USA. It trades on NYSE under ticker CASIF. Primary therapeutic focus areas include Multiple Myeloma, Ovarian Cancer, Advanced Cancer, Recurren
601 Gateway Blvd, San Francisco, CA 94080, US HQ
44 Employees
Public company Type
CASIF · NYSE Ticker
Company details
- Status
- Public
- HQ
- 601 Gateway Blvd, San Francisco, CA 94080, US
- Employees
- 44
- Programs
- 22
- Drugs
- 11
- Patents
- 2
ME-CLN-002
Phase 2 · small molecule · Carcinoid Tumor
ME-CLN-002 for Carcinoid Tumor is a Phase 2 program (small_molecule) at CASI Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code ME-CLN-002
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- CASI Pharmaceuticals
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Carcinoid Tumor
- Status
- completed
- Trials
- 1